Archive for March 2019

At The University of Arizona, Dr. Mansour is a tenured Associate Professor in the Department of Pharmacology/Toxicology in the College of Pharmacy, College of Medicine Division of Translational and Regenerative Medicine, and in the Clinical Translational Sciences program. Dr. Mansour serves as Director of Pharmaceutics/Pharmacokinetics and Director of the PharmD/PhD dual-degree program. Dr. Mansour currently…

Marcie currently is Vice President of Clinical Development for Regeneron. She oversees the clinical development of the Respiratory and Inflammation portfolio which includes development of dupilumab across multiple type 2 inflammatory diseases. She has over 15 years of drug development experience across all stages of development from phase 0 through phase 4 studies and across…

Chris Hogg is a digital health advocate interested in how new forms of health data are changing the relationship between physician and patient. As CCO of Propeller Health, he leads the company’s San Francisco office and oversees the pharma BD, health system and payer sales, clinical and medical affairs and data science teams. Prior to…

John Sheridan is the Director of Research at the Cystic Fibrosis Foundation where he is focused on advancing basic science and translational research to develop nucleic acid therapies that could lead to a one-time cure for CF. Prior to joining the Cystic Fibrosis Foundation, John worked at the National Heart, Lung, and Blood Institute as…

Polly Parsons, MD, ATSF was installed as president for the 2018-2019 term. Dr. Parsons is Professor of Medicine and the E. L. Amidon Chair of the department of medicine at the University of Vermont. Dr. Parsons has long standing interests in research, education, and patient care. Her specific area of research focus is acute lung…

Beran is leading the commercialization of a breakthrough product for the treatment of emphysema, the Zephyr Valve. In his tenure with Pulmonx, Zephyr Valves have had 4 RCTs published, been included in global and national treatment guidelines, won reimbursement across Europe, gained FDA approval, and seen rapid growth. At Pulmonx he has forged close relationships…

Momen M. Wahidi, MD, MBA, is the Director of Interventional Pulmonology and Bronchoscopy at Duke University Medical Center and an Associate Professor of Medicine with Tenure at Duke University School of Medicine. He is also the Chief Medical Officer of the Patient Revenue Management organization at Duke University Health System. Dr. Wahidi is a recognized…

James joined Santé Ventures in 2010. Previously, James served in the Air Force and was the medical director and Vice-Chair of Emergency Medicine at Wilford Hall Medical Center, an academic level-one trauma center in San Antonio. He completed two tours in Iraq as a critical care transport team chief and as the emergency department commander.…